Skip to main content

Cancer Research UK Innovation Summit 2022

Cancer Research UK Innovation Summit 2022

12 May 2022

Cancer Research Horizons is Cancer Research UK's new innovation engine. Our third Innovation Summit will showcase the motives for, and benefits of, translating your research through entrepreneurial commercialisation and the infrastructure available to support you. The programme will include topics covering the incentives for engaging in entrepreneurship and how to overcome the challenges that an entrepreneur may face.

The event will run on 26th May at Newcastle University's Herschel Building.

Learning objectives

This is an excellent opportunity to network with members of the local entrepreneurial ecosystem, with a marketplace exhibit allowing you to engage personally with Cancer Research UK and Cancer Research Horizons, our partners and local industry.

You will hear from:

  • Researchers who have successfully translated their research into commercial products
  • Investors interested in working with cancer researchers like yourselves
  • Successful members of Cancer Research UK-funded spin-out companies
  • Members of Cancer Research Horizons’ translation leadership team

This year’s conference explores:

  • Why engage in entrepreneurship and lessons learned

A panel session with post-doc entrepreneurs on their motivations, successes, and knowledge gained.

  • What route should I take?

An interactive session comparing established routes to commercialisation, ranging from licensing to spin-out.

  • What support is available for me?

An opportunity to gain insight from key members of the local entrepreneurial ecosystem on the infrastructure available in the region to enable commercialisation

Confirmed speakers

  • Tony Hickson, CRUK's Chief Business Officer
  • David Burn, Pro-Vice-Chancellor for the Faculty of Medical Sciences, Newcastle University & Director of Newcastle Health Innovation Partners
  • Ruth Plummer, Professor of Experimental Cancer Medicine at Newcastle University
  • Martina Miotto, Chief Scientific Officer of CellulaREvolution, a successful Newcastle University spin-out company